Select Bibliography

Filter by any of these (after searching):

Burger, Kelli N

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 6 items

Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993)

Atherton, Pamela J. , Burger, Kelli N. , Loprinzi, Charles L. ... - - Support Care Cancer - 2012

Manuscript - Primary - Primary - Symptom Inter - N0993

Patient Reported Outcomes Questionnaire Compliance in Cancer Cooperative Group Trials (Alliance N0992)

Atherton, Pamela J , Burger, Kelli N , Pederson, Levi D ... - - Clin Trials - 2016

Manuscript - Primary - Primary - Health Outcomes - N0992

Phase III, Randomized, Double-Blind, Placebo-Controlled Evaluation of Pregabalin for Alleviating Hot Flashes, N07C1

Loprinzi, Charles L. , Qin, Rui , Baclueva, Ernie P. ... - - J Clin Oncol - 2010

Manuscript - Primary - Primary - Symptom Inter - N07C1

Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5.

Loprinzi, Charles L , Kugler, John W , Barton, Debra L ... - - J Clin Oncol - 2007

Manuscript - Primary - Primary - Symptom Inter - N03C5

Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4)

Neben-Wittich, Michelle A. , Atherton, Pamela J. ... - - Int J Radiat Oncol Biol Phys - 2011

Manuscript - Secondary - Primary - Symptom Inter - N06C4

Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1.

Reeves, Brandi N , Dakhil, Shaker R , Sloan, Jeff A , Wolf, Sherry L ... - - Cancer - 2012

Manuscript - Secondary - Long-Term-Followup - Symptom Inter - N08C1